Daly Richard J — SEC insider filings

SEC reporting owner CIK 1635393. 32 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-12-28 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CATALYST PHARMACEUTICALS, INC. (CPRX)President and CEO, Director26—3 legs · 110,293 sh · $2,490,57665
Aquestive Therapeutics, Inc. (AQST)Director32 legs · 28,025 sh · $99,331—1
OPIANT PHARMACEUTICALS, INC. (OPNT)Director3——9

Insider filings — Daly Richard J

FiledFormIssuerReported transactionsSource
2026-11-124Aquestive Therapeutics, Inc. (AQST)Purchase (P): 1,200 @ $3.53 · Purchase (P): 26,825 @ $3.54EDGAR
2026-11-104Aquestive Therapeutics, Inc. (AQST)Grant/award (A): 57,000 (derivative) @ $0EDGAR
2026-10-163Aquestive Therapeutics, Inc. (AQST)Holdings only — no transactions reportedEDGAR
2026-07-174CATALYST PHARMACEUTICALS, INC. (CPRX)Disposition to issuer (D): 271,266 @ $31.50 · Disposition to issuer (D): 33,500 (derivative) @ $0 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 1,365,319 (derivative) @ $0 · +5 moreEDGAR
2026-01-064CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 42,105 · Tax withholding (F): 10,577 · Option exercise (M): 42,105 (derivative) @ $0EDGAR
2025-12-304CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,334 · Tax withholding (F): 524 · Option exercise (M): 1,334 (derivative) @ $0EDGAR
2025-11-244CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 20,006 · Tax withholding (F): 7,872 · Grant/award (A): 381,948 (derivative) @ $0 · Grant/award (A): 115,283 (derivative) @ $0 · Option exercise (M): 20,006 (derivative) @ $0EDGAR
2025-08-284CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 50,000 @ $2.24 · Sale (S): 22,970 @ $20.62 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2025-06-034CATALYST PHARMACEUTICALS, INC. (CPRX)Sale (S): 70,000 @ $24.86EDGAR
2025-02-194CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,574 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2025-01-034CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 42,105 · Tax withholding (F): 10,600 · Option exercise (M): 42,105 (derivative) @ $0EDGAR
2024-12-314CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,333 · Tax withholding (F): 324 · Option exercise (M): 1,333 (derivative) @ $0EDGAR
2024-11-254CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 491,160 (derivative) @ $0 · Grant/award (A): 60,019 (derivative) @ $0EDGAR
2024-06-054CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 40,000 @ $4.01 · Sale (S): 17,323 @ $15.97 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2024-02-164CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 4,000 · Tax withholding (F): 1,186 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2024-01-034CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 1,365,319 (derivative) @ $0 · Grant/award (A): 210,526 (derivative) @ $0EDGAR
2023-12-294CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0EDGAR
2023-12-114CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 60,000 @ $1.13 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2023-05-164CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 50,000 @ $0.79 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2023-03-034OPIANT PHARMACEUTICALS, INC. (OPNT)Disposition to issuer (D): 5,800 @ $20 · Disposition to issuer (D): 2,000 @ $20 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0 · Disposition to issuer (D): 5,000 (derivative) @ $0 · Disposition to issuer (D): 2,500 (derivative) @ $0EDGAR
2023-02-174CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0EDGAR
2022-12-294CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0EDGAR
2022-12-084CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0EDGAR
2022-08-264CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 40,000 @ $2.53 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2022-06-144OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,000 @ $0EDGAR
2022-02-164CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 12,000 (derivative) @ $0EDGAR
2022-01-264CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 50,000 @ $3.35 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2021-12-304CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-12-064CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0EDGAR
2021-06-164OPIANT PHARMACEUTICALS, INC. (OPNT)Grant/award (A): 2,000 @ $0 · Grant/award (A): 2,500 (derivative) @ $0EDGAR
2021-01-044CATALYST PHARMACEUTICALS, INC. (CPRX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2020-12-284CATALYST PHARMACEUTICALS, INC. (CPRX)Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1635393 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs